|
|
???tair.name??? >
???browser.page.title.author???
|
"l y"???jsp.browse.items-by-author.description???
Showing items 1-10 of 43 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
| 國立成功大學 |
2024-12 |
The efficacy, safety and cell-free DNA of perioperative leucovorin, oxaliplatin, docetaxel and S-1 (LOTS) for locally advanced gastric or gastroesophageal junction adenocarcinoma: A prospective phase II trial
|
Yen;C, C. C.;Chen;I, S.;Chao;Y, J.;Bai;L-Y;Tsai;C, Y.;Jui;P;Hsu;C, Y.;Liao;T, K.;Huang;C-J;Liu;I, T.;Shan;Y-S;Yen;C, J. |
| 國立成功大學 |
2024-09 |
TCOG T5221 trial: A phase II randomized study of gemcitabine and nab-paclitaxel in combination with S-1/LV (GASL) or oxaliplatin (GAP) as first-line treatment for metastatic pancreatic cancer
|
Su;Y-Y;Bai;L-Y;Huang;C-J;Chiu;C-F;Wang;H-T;Du;J-S;Wang;H-C;Chuang;S;Shih;Y-H;Lin;H-C;Shan;Y-S;Chen;L-T |
| 國立成功大學 |
2024-09 |
Phase I/Ib open-label study of an HER2-targeted T cell engager (TCE)-SAR443216 in patients (pts) with advanced solid tumors: Intravenous (IV) dose-escalation results
|
Garcia, Moreno;V;Oh;D-Y;Ryu;M, H.;Calvo;E;Garralda;E;Chung;W-P;Bai;L-Y;Laimito, Rojas;K, I.;Yildirim;O;Masciari;S;Mi;G;Wang;L;Kanlikilicer;P;Buday;B;Rharbaoui;F;Abbadessa;G;Dumbrava;E, E. E. |
| 國立成功大學 |
2024-09 |
CVM-005: Phase IIa study of CVM-1118, a novel oral antivasculogenic mimicry (VM) agent, in advanced neuroendocrine tumors (NET) after progression on prior therapy
|
Yen;C, J.;Chen;M-H;Chen;Y, Y. Y.;Bai;L-Y;Chen;J-S;Hsieh;C-H, J.;Shih;Y-H;Wu;I-C;Chen;Y-L;Chen;C-M;Chao;T-Y;Chu;Y-W;Chien;D-S |
| 國立成功大學 |
2024 |
Performances of full-scale biological nitrogen pre-treatment process for drinking water source: Seasonal variations and microbial community
|
Cheng;H, -H.;Hew;Y, H.;Wu;Y, -J.;Chen;T, -Y.;Chiu;Y, T.;Chen;L, Y.;Lin;T, -F.;Whang;L, -M. |
| 國立成功大學 |
2024 |
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, pl
|
Kang;Y, -K.;Terashima;M;Kim;Y, -W.;Boku;N;Chung;H, C.;Chen;J, -S.;Ji;J;Yeh;T, -S.;Chen;L, -T.;Ryu;M, -H.;Kim;J, G.;Omori;T;Rha;S, Y.;Kim;T, Y.;Ryu;K, W.;Sakuramoto;S;Nishida;Y;Fukushima;N;Yamada;T;Bai;L, -Y.;Hirashima;Y;Hagihara;S;Nakada;T;Sasako;M |
| 國立成功大學 |
2024 |
Treatment Responses to Integrase Strand-transfer Inhibitor-containing Antiretroviral Regimens in Combination with Short-course Rifapentine-based Regimens for Latent Tuberculosis Infection among People with HIV
|
Lin;K, -Y.;Sun;H, -Y.;Yang;C, -J.;Lu;P, -L.;Lee;Y, -T.;Lee;N, -Y.;Liou;B, -H.;Tang;H, -J.;Lee;M, -H.;Wang;N, -C.;Chen;T, -C.;Hii;I, -M.;Huang;S, -H.;Lin;C, -Y.;Tsai;C, -S.;Cheng;C, -Y.;Hung;C, -C.;Chang;S, -Y.;Huang;Y, -S.;Chen;G, -J.;Wu;P, -Y.;Chen;L, -Y.;Chang;H, -Y.;Liu;W, -C.;Su;Y, -C.;Lin;T, -Y.;Tsai;M, -S.;Lee;Y, -C.;Cheng;S, -H.;Huang;Y, -C.;Peng;A, -T.;Lee;Y, -L.;Lin;C, -C.;Lin;S, -P.;Hsieh;C, -Y.;Wang;H, -W.;Ho;M, -W.;Liu;C, -E.;Hung;T, -C.;Chen;Y, -H.;Lee;C, -Y.;Tsai;H, -C.;Lin;H, -H.;Lee;C, -H. |
| 國立成功大學 |
2024 |
Anti-oxidative and anti-inflammatory effects of Ginkgo biloba extract (EGb761) on hindlimb skeletal muscle ischemia–reperfusion injury in rats
|
Chen;L, -Y.;Tai;S, -H.;Hung;Y, -C.;Huang;S, -Y.;Kuo;Z, -C.;Lee;A, -H.;Hsu;H, -H.;Wu;T, -S.;Lee;E, -J. |
| 國立成功大學 |
2024 |
Enhanced hippocampal TIAM2S expression alleviates cognitive deficits in Alzheimer’s disease model mice
|
Sung;K, -C.;Wang;L, -Y.;Wang;C, -C.;Chu;C, -H.;Sun;H, S.;Hsiao;Y, -H. |
| 國立成功大學 |
2024 |
Phase I–II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors
|
Tsimberidou;A, M.;Grothey;A;Sigal;D;Lenz;H, -J.;Hochster;H, S.;Chao;Y;Bai;L, -Y.;Yen;C, -J.;Xu;D;Saville;M, W. |
Showing items 1-10 of 43 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
|
